These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 14371503)

  • 1. [Hypothalamic obesity].
    HERSCHBERG AD; CREFF A
    Presse Med (1893); 1955 Mar; 63(16):325. PubMed ID: 14371503
    [No Abstract]   [Full Text] [Related]  

  • 2. Hypothalamic regulation of food intake.
    Palkovits M
    Ideggyogy Sz; 2003 Sep; 56(9-10):288-302. PubMed ID: 14608950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of malonyl-CoA in heart disease and the hypothalamic control of obesity.
    Folmes CD; Lopaschuk GD
    Cardiovasc Res; 2007 Jan; 73(2):278-87. PubMed ID: 17126822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early life origins of obesity: role of hypothalamic programming.
    Bouret SG
    J Pediatr Gastroenterol Nutr; 2009 Mar; 48 Suppl 1():S31-8. PubMed ID: 19214056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypothalamic sensing of fatty acids.
    Lam TK; Schwartz GJ; Rossetti L
    Nat Neurosci; 2005 May; 8(5):579-84. PubMed ID: 15856066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypothalamic neurons of postnatally overfed, overweight rats respond differentially to corticotropin-releasing hormones.
    Davidowa H; Plagemann A
    Neurosci Lett; 2004 Nov; 371(1):64-8. PubMed ID: 15500968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The hypothalamic H1 receptor: a novel therapeutic target for disrupting diurnal feeding rhythm and obesity.
    Masaki T; Yoshimatsu H
    Trends Pharmacol Sci; 2006 May; 27(5):279-84. PubMed ID: 16584790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Neuroendocrine aspects of obesity].
    Perelló M; Spinedi E
    Medicina (B Aires); 2004; 64(3):257-64. PubMed ID: 15239544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-obesity effects of alpha-lipoic acid mediated by suppression of hypothalamic AMP-activated protein kinase.
    Kim MS; Park JY; Namkoong C; Jang PG; Ryu JW; Song HS; Yun JY; Namgoong IS; Ha J; Park IS; Lee IK; Viollet B; Youn JH; Lee HK; Lee KU
    Nat Med; 2004 Jul; 10(7):727-33. PubMed ID: 15195087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular disruption of hypothalamic nutrient sensing induces obesity.
    He W; Lam TK; Obici S; Rossetti L
    Nat Neurosci; 2006 Feb; 9(2):227-33. PubMed ID: 16415870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endocrine and neuroanatomic features associated with weight gain and obesity in adult patients with hypothalamic damage.
    Daousi C; Dunn AJ; Foy PM; MacFarlane IA; Pinkney JH
    Am J Med; 2005 Jan; 118(1):45-50. PubMed ID: 15639209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of food intake and energy expenditure by hypothalamic malonyl-CoA.
    Lane MD; Wolfgang M; Cha SH; Dai Y
    Int J Obes (Lond); 2008 Sep; 32 Suppl 4():S49-54. PubMed ID: 18719599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin and its evolving partnership with leptin in the hypothalamic control of energy homeostasis.
    Niswender KD; Baskin DG; Schwartz MW
    Trends Endocrinol Metab; 2004 Oct; 15(8):362-9. PubMed ID: 15380807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of starvation-induced activation of AMP-activated protein kinase in the hypothalamus of the Lou/C rats resistant to obesity.
    Taleux N; De Potter I; Deransart C; Lacraz G; Favier R; Leverve XM; Hue L; Guigas B
    Int J Obes (Lond); 2008 Apr; 32(4):639-47. PubMed ID: 18059408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Experimental hypothalamic obesity].
    BOURRAT C; LAMBERT R
    Lyon Med; 1962 Apr; 94():845-74. PubMed ID: 13871941
    [No Abstract]   [Full Text] [Related]  

  • 16. AMP-kinase regulates food intake by responding to hormonal and nutrient signals in the hypothalamus.
    Minokoshi Y; Alquier T; Furukawa N; Kim YB; Lee A; Xue B; Mu J; Foufelle F; Ferré P; Birnbaum MJ; Stuck BJ; Kahn BB
    Nature; 2004 Apr; 428(6982):569-74. PubMed ID: 15058305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional capacity, obesity and hypothalamic involvement: cross-sectional study on 212 patients with childhood craniopharyngioma.
    Müller HL; Faldum A; Etavard-Gorris N; Gebhardt U; Oeverink R; Kolb R; Sörensen N
    Klin Padiatr; 2003; 215(6):310-4. PubMed ID: 14677094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Ghrelin and the gastro-hypothalamic axis].
    Méndez-Sánchez N; Chávez-Tapia NC; Uribe-Esquivel M
    Gac Med Mex; 2006; 142(1):49-58. PubMed ID: 16548293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypothalamic melanocortin signaling and leptin resistance--perspective of therapeutic application for obesity-diabetes syndrome.
    Masuzaki H; Tanaka T; Ebihara K; Hosoda K; Nakao K
    Peptides; 2009 Jul; 30(7):1383-6. PubMed ID: 19394382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional magnetic resonance imaging and immunohistochemical study of hypothalamic function following oral glucose ingestion in rats.
    Chen M; Zhang TM; Luo SL; Zhou C; Wu XM; Zhou NN; Cai K; Yang ZH; Wang WC; Zhao WF; Li SY; Wang Z; Zhang YT; Li GZ
    Chin Med J (Engl); 2007 Jul; 120(14):1232-5. PubMed ID: 17697573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.